Pat Cotroneo
2016
In 2016, Pat Cotroneo earned a total compensation of $2.1M as Chief Financial Officer at FibroGen, a 26% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $233,772 |
|---|---|
| Option Awards | $686,196 |
| Salary | $440,000 |
| Stock Awards | $684,351 |
| Other | $16,976 |
| Total | $2,061,295 |
Cotroneo received $686.2K in option awards, accounting for 33% of the total pay in 2016.
Cotroneo also received $233.8K in non-equity incentive plan, $440K in salary, $684.4K in stock awards and $17K in other compensation.
Rankings
In 2016, Pat Cotroneo's compensation ranked 4,748th out of 14,075 executives tracked by ExecPay. In other words, Cotroneo earned more than 66.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,748 out of 14,075 | 66th |
Division Manufacturing | 1,693 out of 5,489 | 69th |
Major group Chemicals And Allied Products | 527 out of 1,895 | 72nd |
Industry group Drugs | 389 out of 1,538 | 75th |
Industry Pharmaceutical Preparations | 307 out of 1,176 | 74th |
Source: SEC filing on April 24, 2017.
Cotroneo's colleagues
We found three more compensation records of executives who worked with Pat Cotroneo at FibroGen in 2016.